Advertisements
Skip to content

OpGen Inc (OPGN) is more of a gamble than an investment

OpGen Inc (OPGN) currently trades at $2.28 and has fallen by 4.60% today. OPGN went down $0.11 from the previous closing price of $2.39. The high forecast for OpGen Inc is $5.00 and the low is $2.00. The company’s market cap is $27.20 million with a 52 week high of $15.20 and a 52 week low of $0.92. OPGN has changed in price by -9.12 per share in the last 12 months.

Advertisements

OpGen Inc has a weak EPS of -7.7. This means the company lost $-7.7 per share after paying dividends, this can indicate that the stock is a risky investment. EPS is calculated as a company’s profit divided by the outstanding shares of its common stock. The resulting number serves as an indicator of a company’s profitability. It is common for a company to report EPS that is adjusted for extraordinary items and potential share dilution. Based on this information, investorsQ rates this stock 4 out of 10. We give it this rating based on current information written in this article.

Advertisements

About OpGen Inc:
OpGen, Inc. operates as a microbial genetics analysis company. The Company offers a platform for automated and microbial whole genome analysis that brings comparative genomics, whole genome sequence assembly, and strain characterization into the laboratory. OpGen serves customers throughout the United States.

Advertisements

Leave a Reply

%d bloggers like this: